|
|
|
Insider
Information: |
Higgins John L |
Relationship: |
Director |
City: |
Palo Alto |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
2,806,928 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$49,374,432 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
2,806,928 |
|
|
Total
Value |
$49,374,432 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
11
|
Stock
price went up :
|
0
|
5
|
Stock
price went down : |
0
|
6
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
-34.7%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Ligand Pharmaceuticals Inc |
LGND |
Director |
2022-12-28 |
417,695 |
2007-02-01 |
0 |
Premium* |
|
Techne Corp |
TECH |
Director |
2024-05-14 |
36,608 |
2013-10-31 |
0 |
Premium* |
|
OmniAb, Inc |
OABI |
Director |
2024-01-30 |
2,352,625 |
2022-11-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
165 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 6 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
TECH |
Techne Corp |
Director |
|
2018-08-23 |
4 |
OE |
$61.08 |
$610,800 |
D/D |
10,000 |
13,012 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2022-12-16 |
4 |
AS |
$61.87 |
$618,657 |
D/D |
(10,000) |
422,984 |
0 |
% |
|
OABI |
OmniAb, Inc |
Director |
|
2022-11-02 |
4 |
OE |
$2.52 |
$621,553 |
D/D |
246,648 |
2,423,169 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2017-09-05 |
4 |
AS |
$130.00 |
$650,000 |
D/D |
(5,000) |
139,171 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2017-08-08 |
4 |
AS |
$125.00 |
$685,375 |
D/D |
(5,483) |
139,171 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2019-12-20 |
4 |
D |
$105.87 |
$714,517 |
D/D |
(6,749) |
153,614 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2022-11-30 |
4 |
D |
$72.90 |
$714,639 |
D/D |
(9,803) |
416,928 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2017-12-28 |
4 |
D |
$138.66 |
$720,893 |
D/D |
(5,199) |
146,050 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2021-01-25 |
4 |
OE |
$14.47 |
$723,500 |
D/D |
50,000 |
285,310 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2022-02-15 |
4 |
D |
$123.68 |
$732,557 |
D/D |
(5,923) |
340,593 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2017-11-16 |
4 |
S |
$142.53 |
$750,991 |
D/D |
(5,269) |
143,542 |
0 |
- |
|
TECH |
Techne Corp |
Director |
|
2022-08-10 |
4 |
S |
$373.99 |
$751,194 |
D/D |
(1,992) |
6,014 |
0 |
% |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2019-01-23 |
4 |
D |
$111.78 |
$756,192 |
D/D |
(6,765) |
126,090 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2022-11-17 |
4 |
AS |
$78.32 |
$783,173 |
D/D |
(10,000) |
416,731 |
0 |
% |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2021-02-15 |
4 |
D |
$172.46 |
$898,862 |
D/D |
(5,212) |
337,848 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2018-08-30 |
4 |
S |
$258.25 |
$903,875 |
D/D |
(3,500) |
85,419 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2015-06-09 |
4 |
S |
$92.53 |
$928,809 |
D/D |
(10,000) |
126,044 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
President & CEO |
|
2014-01-16 |
4 |
AS |
$64.00 |
$960,000 |
D/D |
(15,000) |
102,099 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2018-02-15 |
4 |
D |
$157.18 |
$981,118 |
D/D |
(6,242) |
96,458 |
0 |
- |
|
TECH |
Techne Corp |
|
|
2019-06-04 |
4 |
S |
$203.67 |
$1,018,346 |
D/D |
(5,000) |
3,526 |
0 |
- |
|
TECH |
Techne Corp |
Director |
|
2020-02-12 |
4 |
S |
$205.23 |
$1,026,133 |
D/D |
(5,000) |
4,021 |
0 |
% |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2022-01-26 |
4 |
D |
$113.68 |
$1,050,744 |
D/D |
(9,243) |
349,018 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2016-03-07 |
4 |
S |
$102.44 |
$1,110,027 |
D/D |
(10,833) |
119,664 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2021-01-25 |
4 |
D |
$156.01 |
$1,160,870 |
D/D |
(7,441) |
243,422 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2021-01-27 |
4 |
OE |
$14.47 |
$1,236,400 |
D/D |
70,000 |
273,422 |
0 |
- |
|
165 Records found
|
|
Page 6 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|